ACTG Publications

TitleAuthorsDateJournalIssueVolume
GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype.Schwarze-Zander, Carolynne ; Blackard, Jason T ; Zheng, Hui ; Addo, Marylyn M ; Lin, Wenyu ; Robbins, Gregory K ; Sherman, Kenneth E ; Zdunek, Dietmar ; Hess, Georg ; Chung, Raymond T ; AIDS Clinical Trial Group A5071 Study Team2006 Aug 15J Infect Dis4194
GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy.Stapleton, Jack T ; Chaloner, Kathryn ; Zhang, Jingyang ; Klinzman, Donna ; Souza, Inara E ; Xiang, Jinhua ; Landay, Alan ; Fahey, John ; Pollard, Richard ; Mitsuyasu, Ronald2009 Mar 13AIDS523
Genetic analysis implicates resistin in HIV lipodystrophy.Ranade, Koustubh ; Geese, William J ; Noor, Mustafa ; Flint, Oliver ; Tebas, Pablo ; Mulligan, Kathleen ; Powderly, William ; Grinspoon, Steven K ; Dubé, Michael P2008 Aug 20AIDS1322
Genetic attributes of cerebrospinal fluid-derived HIV-1 env.Pillai, Satish K ; Pond, Sergei L Kosakovsky ; Liu, Yang ; Good, Benjamin M ; Strain, Matthew C ; Ellis, Ronald J ; Letendre, Scott ; Smith, Davey M ; Günthard, Huldrych F ; Grant, Igor ; Marcotte, Thomas D ; McCutchan, J Allen ; Richman, Douglas D ; Wong, Joseph K2006 JulBrainPt 7129
Genetic predictors of cervical dysplasia in African American HIV-infected women: ACTG DACS 268.Cespedes, Michelle S ; Kerns, Sarah L ; Holzman, Robert S ; McLaren, Paul J ; Ostrer, Harry ; Aberg, Judith A2013 Nov-DecHIV Clin Trials614
A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control.Bartha, István ; Carlson, Jonathan M ; Brumme, Chanson J ; McLaren, Paul J ; Brumme, Zabrina L ; John, Mina ; Haas, David W ; Martinez-Picado, Javier ; Dalmau, Judith ; López-Galíndez, Cecilio ; Casado, Concepción ; Rauch, Andri ; Günthard, Huldrych F ; Bernasconi, Enos ; Vernazza, Pietro ; Klimkait, Thomas ; Yerly, Sabine ; O'Brien, Steph2013Elife2
Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202.Johnson, Daniel H ; Venuto, Charles ; Ritchie, Marylyn D ; Morse, Gene D ; Daar, Eric S ; McLaren, Paul J ; Haas, David W2014 AprPharmacogenet Genomics424
Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group Study.Henrich, Timothy J ; McLaren, Paul J ; Rao, Suhas S P ; Lin, Nina H ; Hanhauser, Emily ; Giguel, Francoise ; Gulick, Roy M ; Ribaudo, Heather ; DE Bakker, Paul I W ; Kuritzkes, Daniel R2014 MarOpen Forum Infect Dis11
Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.Leger, Paul D ; Johnson, Daniel H ; Robbins, Gregory K ; Shafer, Robert W ; Clifford, David B ; Li, Jun ; McLaren, Paul J ; Haas, David W2014 JunJ Neurovirol320
Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants.Holzinger, Emily R ; Grady, Benjamin ; Ritchie, Marylyn D ; Ribaudo, Heather J ; Acosta, Edward P ; Morse, Gene D ; Gulick, Roy M ; Robbins, Gregory K ; Clifford, David B ; Daar, Eric S ; McLaren, Paul ; Haas, David W2012 DecPharmacogenet Genomics1222
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.Wanga, Valentine ; Venuto, Charles ; Morse, Gene D ; Acosta, Edward P ; Daar, Eric S ; Haas, David W ; Li, Chun ; Shepherd, Bryan E2015 SepPharmacogenet Genomics925
Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.Lehmann, David S ; Ribaudo, Heather J ; Daar, Eric S ; Gulick, Roy M ; Haubrich, Richard H ; Robbins, Gregory K ; DE Bakker, Paul I W ; Haas, David W ; McLaren, Paul J2015 FebPharmacogenet Genomics225
Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial.Lorenzana, Sarah B ; Hughes, Michael D ; Grinsztejn, Beatriz ; Collier, Ann C ; Luz, Paula Mendes ; Freedberg, Kenneth A ; Wood, Robin ; Levison, Julie H ; Mugyenyi, Peter N ; Salata, Robert ; Wallis, Carole L ; Weinstein, Milton C ; Schooley, Robert T ; Walensky, Rochelle P2012 Jun 1AIDS926
Genotypic susceptibility scores and HIV type 1 RNA responses in treatment-experienced subjects with HIV type 1 infection.Anderson, Jeffrey A ; Jiang, Hongyu ; Ding, Xiao ; Petch, Leslie ; Journigan, Terri ; Fiscus, Susan A ; Haubrich, Richard ; Katzenstein, David ; Swanstrom, Ronald ; Gulick, Roy M ; AIDS Clinical Trials Group Study 359 Protocol Team2008 MayAIDS Res Hum Retroviruses524
Greater suppression of nevirapine resistance with 21- vs 7-day antiretroviral regimens after intrapartum single-dose nevirapine for prevention of mother-to-child transmission of HIV.McMahon, Deborah K ; Zheng, Lu ; Hitti, Jane ; Chan, Ellen S ; Halvas, Elias K ; Hong, Feiyu ; Kabanda, Joseph ; Taulo, Frank ; Kumarasamy, Nagalingeswaran ; Bonhomme, Jerry ; Wallis, Carole L ; Klingman, Karin L ; Hughes, Michael D ; Mellors, John W2013 AprClin Infect Dis756